In patients with temporal lobe epilepsy, 5-HT1A levels were reduced in the hippocampus, temporal cortex, amygdala, and frontal lobe ipsilateral to the epileptic activity, leading to a decline in the serotonin-induced anti-epileptic effect [83]. This evidence concerns the gene HTR1A and temporal lobe epilepsy.